ATTENTION: Please enable Javascript in your browser for full site functionality.
Skip to navigation Skip to main content Skip to footer

Recalls and Alerts

Class 4 Caution in Use

Class 4 Caution in Use on Memantine 10mg Film-Coated Tablets

Crescent Pharma Ltd has informed us of a discrepancy on the product packaging for the below batches. The discrepancy relates to the incorrect quantity printed on one side (end flap) of the packs in error. The incorrect end flap states that the quantity of tablets within the pack is 30, however this is incorrect and should state 28 as per all other sides of the pack, (see Annex 1). The other product details on the pack including the name, strength and pharmaceutical form of the medicine are correct.

Please visit the: MHRA website for more details on this drug alert.

The affected products' details are as follows:

PIP CodeProduct DescriptionSupplierAffected Batch
8130825MEMANTINE HYD TAB 10MGCRESCENT PHARMA LTD10819
20819
11119
1208925MEMANTINE TABS 10MGCRESCENT PHARMA LTD10819
20819
11119
1182922MEMANTINE HCL TAB 10MGCRESCENT PHARMA LTD10819
20819
11119
1148048MEMANTINE TAB 10MGCRESCENT PHARMA LTD10819
20819
11119

This may have been supplied by AHDL. Unfortunately we are not providing specific batch information you will be required to follow the instructions as per the drug alert.

For more information or medical information queries, please contact: Crescent Pharma Ltd. Medical Information Department on +00351 214643225, via email on tiago.barca@pharsolution.com or +44 (0) 1256 772740.

Recipients of this Drug Alert should bring it to the attention of relevant contacts.

 

This is a caution in use only we are not accepting stock returns.

If you have any questions, then please contact your local Service Centre Customer Services team.